Subtopic Deep Dive
Left Ventricular Thrombus
Research Guide
What is Left Ventricular Thrombus?
Left ventricular thrombus (LVT) is a blood clot forming in the left ventricle, often after acute myocardial infarction, detectable by echocardiography and managed with anticoagulation to prevent embolization.
Studies show LVT incidence reaches 40% in anterior transmural myocardial infarction using serial two-dimensional echocardiography (Asinger et al., 1981, 582 citations). Contrast-enhanced MRI outperforms transthoracic and transesophageal echocardiography for LVT detection with pathological validation (Srichai et al., 2006, 435 citations). Post-MI LVT formation links to reduced mortality via primary PCI, yet requires risk stratification (Delewi et al., 2012, 350 citations).
Why It Matters
LVT post-MI elevates stroke risk, with Asinger et al. (1981) reporting 40% incidence in anterior wall infarcts, guiding anticoagulation in high-risk patients. Srichai et al. (2006) demonstrated MRI's superior sensitivity (88%) over echocardiography (41-67%) for accurate diagnosis, reducing embolic events in 112 validated cases. Delewi et al. (2012) highlighted PCI's role in lowering LVT prevalence from historical 60% to under 5%, impacting guideline-directed therapy for millions annually.
Key Research Challenges
Accurate Noninvasive Detection
Echocardiography misses small or mural LVT, with sensitivity below 70% versus pathology. Srichai et al. (2006) found MRI at 88% sensitivity outperforms TTE (41%) and TEE (67%). Challenge persists in real-time clinical settings without validation.
Risk Stratification Post-MI
Predicting LVT in anterior MI patients varies by akinesis extent, but no universal model exists. Asinger et al. (1981) linked severe wall motion abnormalities to 60% risk versus 0% in inferior MI. Delewi et al. (2012) note evolving PCI effects complicating incidence estimates.
Optimal Anticoagulation Duration
Balancing thrombus resolution against bleeding lacks randomized data. Delewi et al. (2012) review shows variable outcomes with warfarin, but no consensus on 3-6 month therapy. Imaging follow-up challenges persist without standardized protocols.
Essential Papers
Incidence of Left-Ventricular Thrombosis after Acute Transmural Myocardial Infarction
Richard Asinger, Frank L. Mikell, Joseph Elsperger et al. · 1981 · New England Journal of Medicine · 582 citations
To study the incidence of left-ventricular thrombosis after transmural myocardial infarction, we performed serial two-dimensional echocardiography in 70 consecutive patients. Thirty-five patients h...
Clinical and Echocardiographic Characteristics of Papillary Fibroelastomas
Jing Sun, Craig R. Asher, Xing Sheng Yang et al. · 2001 · Circulation · 493 citations
Background —Cardiac papillary fibroelastoma (CPF) is a primary cardiac neoplasm that is increasingly detected by echocardiography. The clinical manifestations of this entity are not well described....
Free-Floating Thrombi in the Right Heart
Ludovic Chartier, J Bera, M Delomez et al. · 1999 · Circulation · 468 citations
Background —Floating right heart thrombi (FRHTS) are a rare phenomenon, encountered almost exclusively in patients with suspected or proven pulmonary embolism and diagnosed by transthoracic echocar...
Clinical, imaging, and pathological characteristics of left ventricular thrombus: A comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation
Monvadi B. Srichai, Chelif Junor, L. Leonardo Rodriguez et al. · 2006 · American Heart Journal · 435 citations
The pathophysiology of chronic thromboembolic pulmonary hypertension
Gérald Simonneau, Adam Torbicki, Peter Dorfmüller et al. · 2017 · European Respiratory Review · 428 citations
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive pulmonary vascular disease that is usually a consequence of prior acute pulmonary embolism. CTEPH usually begins with pe...
Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation
Antonio Berruezo, David Tamborero, Lluı́s Mont et al. · 2007 · European Heart Journal · 407 citations
Hypertension and LAD are independent pre-procedural predictors of AF recurrence after CPVA to treat AF. These data may help in patient selection for AF ablation.
Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation
Randall K. Wolf, Eric W. Schneeberger, Robert Osterday et al. · 2005 · Journal of Thoracic and Cardiovascular Surgery · 402 citations
Reading Guide
Foundational Papers
Start with Asinger et al. (1981, 582 citations) for core incidence data via serial echocardiography in 70 MI patients; follow Srichai et al. (2006, 435 citations) for imaging validation against pathology.
Recent Advances
Delewi et al. (2012, 350 citations) updates LVT risks in PCI era; Chartier et al. (1999, 468 citations) informs on related floating thrombi management.
Core Methods
Serial two-dimensional echocardiography (Asinger et al., 1981); contrast-enhanced MRI, TTE, TEE with surgical validation (Srichai et al., 2006).
How PapersFlow Helps You Research Left Ventricular Thrombus
Discover & Search
Research Agent uses searchPapers('left ventricular thrombus post-MI incidence') to retrieve Asinger et al. (1981, 582 citations), then citationGraph reveals Delewi et al. (2012) and Srichai et al. (2006) clusters, while findSimilarPapers expands to 50+ related thrombi studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Srichai et al. (2006) to extract MRI sensitivity metrics, verifies claims via verifyResponse (CoVe) against Asinger et al. (1981) data, and uses runPythonAnalysis for statistical comparison of detection rates (e.g., pandas t-test on 88% vs 41% sensitivity). GRADE grading scores Asinger's cohort study as moderate evidence for incidence claims.
Synthesize & Write
Synthesis Agent detects gaps like missing RCTs on anticoagulation duration from Delewi et al. (2012), flags contradictions in echo sensitivity between Srichai et al. (2006) and Asinger et al. (1981), then Writing Agent uses latexEditText, latexSyncCitations for LVT review draft and latexCompile for PDF with exportMermaid timelines of thrombus evolution.
Use Cases
"Compute LVT incidence rates from post-MI cohorts in top papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of Asinger 40% and Delewi <5% rates) → matplotlib incidence plot output.
"Draft LaTeX review on LVT imaging modalities"
Research Agent → citationGraph on Srichai et al. → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Asinger, Delewi) → latexCompile → camera-ready PDF.
"Find analysis code for echo vs MRI LVT detection"
Research Agent → paperExtractUrls from Srichai et al. → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified stats scripts for imaging comparison.
Automated Workflows
Deep Research workflow scans 50+ LVT papers via searchPapers → citationGraph → structured report with GRADE-scored incidence from Asinger et al. (1981). DeepScan applies 7-step CoVe verification on Delewi et al. (2012) anticoagulation claims, checkpointing echo data against Srichai et al. (2006). Theorizer generates hypotheses on MRI-guided therapy from detection gaps.
Frequently Asked Questions
What is left ventricular thrombus?
LVT is a clot in the left ventricle, primarily post-anterior MI due to stasis from akinesis (Asinger et al., 1981).
What are main detection methods?
Serial two-dimensional echocardiography detects 40% incidence (Asinger et al., 1981); contrast MRI achieves 88% sensitivity with pathology validation (Srichai et al., 2006).
What are key papers on LVT?
Asinger et al. (1981, 582 citations) on post-MI incidence; Srichai et al. (2006, 435 citations) on imaging comparison; Delewi et al. (2012, 350 citations) on PCI era formation.
What open problems exist in LVT research?
Optimal anticoagulation duration lacks RCTs; real-time risk models post-PCI need validation; small LVT detection sensitivity remains under 70% by echo.
Research Cardiac tumors and thrombi with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Left Ventricular Thrombus with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cardiac tumors and thrombi Research Guide